Powder: -20°C for 3 years | In solvent: -80°C for 1 year
VP3.15 dihydrobromide is a potent, orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE7- glycogen synthase kinase (GSK)3 inhibitor(with IC50s of 1.59 μM , 0.88 μM,respectively.)
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 39.00 | |
5 mg | In stock | $ 64.00 | |
10 mg | In stock | $ 97.00 | |
25 mg | In stock | $ 228.00 | |
50 mg | In stock | $ 396.00 | |
100 mg | In stock | $ 589.00 | |
500 mg | In stock | $ 1,280.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 74.00 |
Description | VP3.15 dihydrobromide is a potent, orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE7- glycogen synthase kinase (GSK)3 inhibitor(with IC50s of 1.59 μM , 0.88 μM,respectively.) |
Targets&IC50 | PDE7:1.59 μM, GSK-3:0.88 μM |
Molecular Weight | 528.3 |
Formula | C20H24Br2N4OS |
CAS No. | 1281681-33-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22.5 mg/mL (42.59 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
VP3.15 dihydrobromide 1281681-33-1 Metabolism PI3K/Akt/mTOR signaling Stem Cells PDE GSK-3 Glycogen synthase kinase-3 inhibit VP3.15 Inhibitor VP-3.15 dihydrobromide Glycogen synthase kinase 3 VP3.15 Dihydrobromide Phosphodiesterase (PDE) inhibitor